Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery

References

• Wong IB, Nischal KK. Managing a child with an external ocular disease. J AAPOS 2010;14:68–77
   PubMed Web of Science ®Google Scholar
• Jones SM, Weinstein JM, Cumberland P, et al. Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis. Ophthalmology 2007;114:2271–80
   PubMed Web of Science ®Google Scholar
• Viswalingam M, Rauz S, Morlet N, et al. Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol 2005;89:400–3
   PubMed Web of Science ®Google Scholar
• Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Family Physician 2010;81:137–44
   PubMed Web of Science ®Google Scholar
• Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477–80
   PubMed Web of Science ®Google Scholar
• Fraunfelder FT. Extraocular fluid dynamics: how best to apply topical ocular medication. Transact Am Ophthalmol Soc 1976;74:457–87
   PubMedGoogle Scholar
• Boddu SH, Gunda S, Earla R, et al. Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye. Bioanalysis 2010;2:487–507
   PubMed Web of Science ®Google Scholar
• Schoenwald RD, Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci 1980;69:391–4
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827–40
   PubMed Web of Science ®Google Scholar
• Saettone MF, Burgalassi S, Giannaccini B. Preparation and evaluation in rabbits of topical solutions containing forskolin. J Ocular Pharmacol 1989;5:111–18
   PubMedGoogle Scholar
• Hui HW, Robinson JR. Effect of particle dissolution rate on ocular drug bioavailability. J Pharm Sci 1986;75:280–7
   PubMed Web of Science ®Google Scholar
• Robin JS, Ellis PP. Ophthalmic ointments. Survey Ophthalmol 1978;22:335–40
   PubMed Web of Science ®Google Scholar
• ller F, Wagner M, Neubert RHH. Comparative in vitro investigation of the forces exerted by eye drops and eye spray. Die Pharmazie – An Int J Pharm Sci 2005;60:630–1
   Google Scholar
• Overaker RF, Dodge BC, Epstein DL. A new eyedrop dispensing bottle. Am J Ophthalmol 1999;128:368–70
   PubMed Web of Science ®Google Scholar
• Smith SE. Eyedrop instillation for reluctant children. Br J Ophthalmol 1991;75:480–1
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, et al. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–617
   Google Scholar
• Coelho JF, Ferreira PC, Alves P, et al. Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J 2010;1:164–209
   PubMedGoogle Scholar
• Valencia PM, Farokhzad OC, Karnik R, et al. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nature Nanotechnology 2012;7:623–9
   PubMed Web of Science ®Google Scholar
• Ogawa TWHCA, Isowaki AWHCA. Inventors transdermal drug delivery system and method of using the same. US patent US 2012/0321673 A1; 2012
   Google Scholar
• Morales ME, Clares B, Lopez-Viota M, et al. Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery. Drug Deliv 2009;16:1–10
   PubMed Web of Science ®Google Scholar
• Pandey M, Belgamwar V, Gattani S, et al. Pluronic lecithin organogel as a topical drug delivery system. Drug Deliv 2010;17:38–47
   PubMed Web of Science ®Google Scholar
• Ruiz MA, Clares B, Morales ME, et al. Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles. Pharm Dev Technol 2007;12:637–44
   PubMed Web of Science ®Google Scholar
• Said T, Dutot M, Christon R, et al. Benefits and side effects of different vegetable oil vectors on apoptosis, oxidative stress, and P2X7 cell death receptor activation. Investigative Ophthalmol Visual Sci 2007;48:5000–6
   PubMed Web of Science ®Google Scholar
• Vieira C, Evangelista S, Cirillo R, et al. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation. Mediat Inflam 2000;9:223–8
   PubMed Web of Science ®Google Scholar
• Vieira C, Fetzer S, Sauer SK, et al. Pro- and anti-inflammatory actions of ricinoleic acid: similarities and differences with capsaicin. Naunyn Schmiedebergs Arch Pharmacol 2001;364:87–95
   PubMed Web of Science ®Google Scholar
• Novak A, Clark G, Dupuy H. Antimicrobial activity of some ricinoleic acid oleic acid derivatives. J Am Oil Chem Soc 1961;38:321–4
   Web of Science ®Google Scholar
• Scoper SV, Kabat AG, Owen GR, et al. Ocular distribution, bactericidal activity and settling characteristics of TobraDex® ST ophthalmic suspension compared with TobraDex® ophthalmic suspension. Adv Therapy 2008;25:77–88
   PubMed Web of Science ®Google Scholar
• Baloglu E, Karavana, SY, Senyigit, ZA, Guneri, T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharm Dev Technol 2011;16:627–36
   PubMed Web of Science ®Google Scholar
• Ryan JA. Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2, 4‐dinitrofluorobenzene. J Pharm Sci 1984;73:1301–2
   PubMed Web of Science ®Google Scholar
• Boddu SH, Jwala J, Vaishya R, et al. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocular Pharmacol Therap 2010;26:37–48
   PubMed Web of Science ®Google Scholar
• Valjakka-Koskela R, Kirjavainen M, Monkkonen J, et al. Enhancement of percutaneous absorption of naproxen by phospholipids. Int J Pharm 1998;175:225–30
   Web of Science ®Google Scholar
• Mohanty A, Das C, Dash S, et al. Physico-chemical and antimicrobial study of polyherbal formulation. Glob Pharm 2010;4:1–3
   Google Scholar